Common side effects include nausea or vomiting, constipation, bloating, diarrhea, and low energy
To make it clearer, heres a quick comparison: Best Practices in Handling: The Human Factor You can have the perfect temperature and the right diluent, but sloppy technique can undo it all
And most insurers follow what Medicare does. The new drug certainly wont be a cure-all for obesity, Krashes adds
It is important not to stop or delay evidence-based DMARD or biologic therapy in favour of experimental GLP-1 therapy outside a clinical trial
A few6 to consider: Efficacy - not all weight loss patients need to lose much weight
Possible reasons include Type 1 diabetes diagnosis, advanced Type 2 diabetes with severely depleted beta cells, contraindication to GLP-1 drugs (thyroid cancer history, pancreatitis history), insurance or cost barriers, prior GLP-1 intolerance, or very high blood sugar requiring immediate insulin coverage